ABCL Cumulative FCF
The running total of free cash flow across the series, showing cumulative cash generated to date.
Cumulative FCF
Latest: -$495M (2026Q2)
| Period | Value |
|---|---|
| 2023Q1 | -$59M |
| 2023Q2 | -$66M |
| 2023Q3 | -$87M |
| 2023Q4 | -$121M |
| 2024Q1 | -$187M |
| 2024Q2 | -$237M |
| 2024Q3 | -$284M |
| 2024Q4 | -$308M |
| 2025Q1 | -$330M |
| 2025Q2 | -$376M |
| 2025Q3 | -$437M |
| 2025Q4 | -$482M |
| 2026Q1 | -$519M |
| 2026Q2 | -$495M |
Other Indicators
Other ABCL Charts
More quarter-by-quarter fundamentals for AbCellera Biologics Inc.
1 / 6
Revenue
EPS
Free Cash Flow
FCF Margin
Shares Outstanding
Total Assets
Healthcare Comparison
1 / 3
Cumulative FCF
Cumulative FCF
Cumulative FCF
Latest Cumulative FCF: -$495M (2026Q2); -31.8% YoY.
Across the 14 quarters from 2023Q1 to 2026Q2, Cumulative FCF ranged from -$519M in 2026Q1 to -$59M in 2023Q1.